CubiSafe aims to develop an additive that can be incorporated into paints, disinfectants, and fabrics to make them bacteria-resistant. This would help address the major issues caused by hospital-acquired infections which kill 100,000 people annually. The business model involves partnering with manufacturers to incorporate CubiSafe into their products and share revenue. Financial projections estimate $67.5 million in annual revenue and $43.9 million in operating profit by year 5. Key risks include new partnerships, low barriers to entry, and supply chain dynamics, which the company aims to mitigate through strategic partnerships, patent protection, and market sensing.
2. +
Agenda
Raison detre
Opportunity
Business Model
Value Creation
Value Delivery
Value Capture
Navigating uncertainties
Risk and mitigation
Conclusion
3. +
Raison d'être: Saving lives
Saving lives
Core competency:
Innovation and New Product
Development
Market leader in anti-
bacterial
Differentiated culture
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
4
4. +
HAI: Disguised Opportunity
100,000 individuals killed every year
$45 billion in cost
Antibiotic resistance is rising
Pressing concern for Hospitals
$2 Billion in
global revenue –
majority from
organic growth
Balanced and
unique pipeline
strategy
Leverage
disciplined
investments to
generate $700mn
in non-GAAP
income
A highly differentiated Culture
Disciplined new
business
development
Unique pipeline
for development –
focus on anti-
bacterial space
Investment in
future technology
Promote innovative culture
Raison
detre
Opportunity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusi
on
5
5. +
Value Creation
• Customer pain-points
• Product Conception
• Product Definition
Value Delivery
• Channels
• Marketing
• Organizational
restructuring
Value Capture
• Pricing
• Creating sustainable
shareholder value
Opportunity realization
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
6
6. +
Value Creation: Pain-point
Human touch points –
Thriving ground for bacteria
colonies
Improbable to eradicate
completely by routine
cleaning
Causes health complications
to existing patients and
visitors
No change in current protocols and infrastructure, with
a product that kills bacteria.
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
7
7. +
CubiSafe
No additional step
Seamless integration with
existing products
Wider reach
No additional procurement
of products
CubiSafe: An additive that can be incorporated in the
paint, disinfectants and fabrics making them
bacteria resistant.
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
8
8. +
Partnership v/s product strategy
Hedging risk of entering new market
Creating a hurdle for brand value dilution
REACH – Cannot manufacture various products but can reach
all products with one solution – CubiSafe
Safety net for Cubist’s Pharma brand in case pilot is not
successful in the new market
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
9
9. +
Delivery Medium-
Paints
Disinfectants
Fabrics
Channel selection criteria
Brand Image
Access to end consumer
Market Leadership
Legal Agreement
Value Delivery
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
CubiSafe Inside – A mark of
safety and 100% guarantee
Think Intel Inside!!
10
10. +
Value Delivery
Partnership with
OEM’s
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
New marketing
strategy
Cubist
(owns
molecule)
Manufacturing
Partner
Material
Supplies
Procurement
OEMs
(Customers)
Hospitals
Products
with
CubiSafe
Safer
Hospital
Environment
SAVE
LIVES
11
13. +
Financials
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
14
(In $ Thousands) Year 1 Year 2 Year 3 Year 4 Year 5
Revenu
e
Paint $1,500 $2,250 $3,750 $4,200 $4,500
Spray 13,500 20,250 33,750 37,800 40,500
Linen 7,500 11,250 18,750 21,000 22,500
Total Revenue 22,500 33,750 56,250 63,000 67,500
Cost of Goods Sold 1,350 2,025 3,375 3,780 4,050
Gross Margin 21,150 31,725 52,875 59,220 63,450
Research &
Development 3,375 3,375 28,123 1,890 675
Selling, General and
Admin. 4,500 6,750 12,398 15,750 18,900
Operating Expenses 7,875 10,125 40,521 17,640 19,575
Operating Profit $13,275 $21,600 $12,354 $41,580 $43,875
14. +
Navigating through uncertainties
Entrepreneurial Though and Action ®
Fail fast learn quick
Cubist Capital
Partner with Babson and likes
Create an incubator to keep innovations flourishing
Hampers negative attitude and fosters healthy competition
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
15
15. +
Conclusion
CubiSafeQuick positive
cash flow
Fractional
R&D cost
Quick to
market
Testimony
for
employess Business
diversification
opportunity
Standard
for
Bacteria
Removal
Entrepreneurial
thought and
action
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusion
16
18. +
Risk and Mitigation
New partner alliances
Low barrier to entry
Not an end product
No credibility in this space
Supply chain dynamics
Pricing
Cannibalization
Co-branding
Partner with credible players
Increase barriers by
establishing brand early on
Discerning market sensing
If you do not address someone
else will – look at it as
opportunity
Patent – With application
Raison
detre
Opportun
ity
Business
Model
Value
Creation
Value
Delivery
Value
Capture
Navigating
uncertainti
es
Risk and
mitigatio
n
Conclusio
n
19